Clinical Trial Update: Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated three formulations of the AMA-1 malaria vaccine in healthy Dutch adult volunteers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• AMA-1 vaccine candidate (AMA-1 vaccine)

Snippet

Sponsor: European Vaccine Initiative | Conditions: Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED